David, CEO of Honeydew, built a teledermatology platform after his own severe cystic acne went untreated. The startup uses AI to automate prescriptions for drugs like Accutane, cutting costs to $40 monthly. It's already served 2,000 patients and is growing 25% month-over-month.
Chapters
This founder has 60 seconds to pitch their business. Watch to the end to see how much I would invest. Hi, I'm David, the co-founder and CEO of Honeydew. We're ridding the world of skin diseases with the help of clinically trained AI. I started the company as a patient who suffered from severe cystic acne for 10 years, and I started it with the dermatologist who actually cleared my skin and the guy who wrote the textbook that's used to train every other dermatologist in the country. We partnered up because 90 million people with a treatable skin disease aren't getting treatment. Because we have massive clinician shortages in the US. It costs hundreds to thousands of dollars a month to get treatment, and the ones that actually work, like Accutane for acne care, they're administratively complex or even regulated, and most derms just don't want to deal with it. We solve this problem with our platform by automating the workflows for these medications, and we get it directly to patients for as low as $40 a month. We're also building an AI tool that people can communicate directly with for expert guidance for free. We launched just over a year ago. We have over 2,000 patients already. We're growing 25% month over month, and we'll be in all 50 states by the end of Q2. Thank you.
